title: Intracranial ependymoma: long-term results of a policy of surgery and radiotherapy.
abstract: Ninety-three patients with primary intracranial ependymoma were treated at the Royal Marsden Hospital, between 1952 and 1988, with postoperative radiotherapy. The survival probability at 5, 10, and 15 years was 51%, 42% and 31%, respectively, and the corresponding progression free survival (PFS) probability, 41%, 38%, and 30%. Tumor grade was the single most important prognostic factor for survival and PFS with gender of lesser prognostic significance. Treatment parameters were stratified for grade. In patients with low grade tumors survival and PFS were better following complete macroscopic excision compared to incomplete surgery. The extent of resection had no significant influence on survival or PFS in patients with high grade tumors. Extent of irradiation did not influence PFS, irrespective of tumor grade, while patients with high grade tumors had marginally better survival following extensive irradiation compared to more limited radiotherapy. The main problem in the treatment of ependymoma remains local progression which was the cause of death in all but two patients. New treatment strategies should focus on improvement of local control, especially in incompletely resected low grade tumors and all high grade tumors. The use of spinal irradiation is unlikely to significantly improve treatment results.
authors.affiliation: Neuro-oncology Unit, Royal Marsden Hospital, Sutton, Surrey, UK.
authors.forename: L J
authors.initials: LJ
authors.lastname: Vanuytsel
authors.forename: E M
authors.initials: EM
authors.lastname: Bessell
authors.forename: S E
authors.initials: SE
authors.lastname: Ashley
authors.forename: H J
authors.initials: HJ
authors.lastname: Bloom
authors.forename: M
authors.initials: M
authors.lastname: Brada
mesh_terms: D000293:Adolescent; D000328:Adult; D001932:Brain Neoplasms / Q000453:epidemiology / Q000532:radiotherapy* / Q000601:surgery*; D002648:Child; D002675:Child, Preschool; D003131:Combined Modality Therapy; D004806:Ependymoma / Q000453:epidemiology / Q000532:radiotherapy* / Q000601:surgery*; D005260:Female; D006801:Humans; D015192:Infratentorial Neoplasms / Q000453:epidemiology / Q000532:radiotherapy* / Q000601:surgery; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D015173:Supratentorial Neoplasms / Q000453:epidemiology / Q000532:radiotherapy / Q000601:surgery; D016019:Survival Analysis; D015996:Survival Rate; D013997:Time Factors; D006113:United Kingdom / Q000453:epidemiology